Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Nuclear Stress Test for Heart Failure Can Identify More Than Blockages

By HospiMedica International staff writers
Posted on 13 Aug 2008
A less invasive imaging test typically used to diagnose coronary disease may be used to detect one of the leading causes of heart failure. More...


Researchers from the Medical College of Georgia (MCG; Augusta, USA) are using a nuclear stress modality to look at how fast blood flows into the heart's left ventricle so that they can determine if it is having difficulty. When the ventricle fails to correctly fill with blood because it is stiff and unable to relax, it is termed diastolic dysfunction, accounting for 40-60% of patients with heart failure, according to the American Heart Association. When it occurs, the left side of the heart pumps too little blood while the right side continues to pump normally, and the lungs fill up with blood.

"If someone has a slow fill rate, that means the left ventricle is not relaxed enough to get enough blood,” said Dr. Dineshkumar Patel, internal medicine resident at MCG. "And if the left ventricle cannot receive enough blood, then it cannot collect enough blood to be pumped out to the rest of the body. There is a four-fold increase in morbidity and mortality when diastolic dysfunction is present in patients with coronary disease.”

It is easier for physicians to evaluate the systolic function using an echocardiogram and cardiac catheterization, according to Dr. Patel. An echocardiogram utilizes an ultrasound beam that travels through the front of the chest wall and lungs to the heart, while cardiac catheterization is a very invasive procedure using a thin plastic tube, which is inserted into an artery or vein in the arm or leg and advanced into the chambers of the heart.

"But not all patients can undergo this test because it is so invasive,” Dr. Patel added. "And it's difficult to diagnose diastolic dysfunction with these [tests] when the systolic function is normal because you can have a perfectly normal pumping heart and still have this condition.”

Dr. Patel and collaborator Dr. Vincent Robinson looked at 52 consecutive patients who underwent cardiac catheterization within 15 days of a nuclear stress test to evaluate the efficacy in diagnosing diastolic dysfunction. During a nuclear stress test, radioactive thallium is injected into the bloodstream to show how well blood flows to the heart muscle. Scans are taken shortly after an exercise test to show blood flow when the heart is stressed and two or three hours later to show blood flow during rest. "This test is usually used to identify blockages in the heart,” Dr. Patel explained. "But in addition to the blockages, we have demonstrated that it also shows the left ventricle filling pressure, thus giving us an excellent prognostic value in predicting diastolic dysfunction because when the filling pressure is too high, the left ventricle has a hard time receiving blood.”

Dr. Patel and the MCG nuclear cardiology researchers compared the diastolic filling pressure from the catheterization and from the nuclear stress test and found that the latter had 94% specificity in detecting diastolic dysfunction (i.e., high filling pressure at cardiac catheterization).

The nuclear stress test plots out a heartbeat in 16 frames, and that represents the diastolic filling curve at 16 points, like taking a melon and slicing it into 16 even pieces, according to Dr. Robinson, nuclear cardiologist at MCG and faculty adviser on the study. The slope of the filling portion of the curve is a representation of the left ventricle filling pressure used as a marker of diastolic dysfunction.

"We have discovered that just looking at these markers can tell us whether a patient has diastolic dysfunction or not,” noted Dr. Robinson. "Diastolic function is a major prognostic factor in these patients with coronary disease. Previously, the nuclear stress test was only detecting diastolic dysfunction in patients who were already sick, whose hearts were weak and barely pumping. In other words, the test only picked up patients who had diastolic and systolic dysfunction. But now, we can use the diastolic filling curve on a nuclear stress test to diagnose patients with diastolic dysfunction who have normally squeezing hearts.”

An individual can be in great physical shape and still have diastolic dysfunction, according to Dr. Patel. "We can prevent heart failure before you start complaining of chest pain and shortness of breath.”

The study was published in the May 2008, issue of the Journal of Nuclear Medicine (JNM).

Related Links:
Medical College of Georgia


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.